ImageneBio Revenue

ImageneBio had revenue of $800.00K in the twelve months ending September 30, 2025. In the year 2024, ImageneBio had annual revenue of $3.50M, down -56.04%.

Revenue (ttm)

$800.00K

Revenue Growth

-56.04%

P/S Ratio

86.41

Revenue / Employee

n/a

Employees

n/a

Market Cap

68.49M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.50M	-4.46M	-56.04%
Dec 31, 2023	7.96M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

IMA News

4 weeks ago - ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team - GlobeNewsWire
4 weeks ago - ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences - GlobeNewsWire
4 months ago - ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
4 months ago - Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million - GlobeNewsWire
5 months ago - Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company - GlobeNewsWire
5 months ago - Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals - GlobeNewsWire
5 months ago - Ikena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Merger with Inmagene Biopharmaceuticals - GlobeNewsWire
1 year ago - Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement - GlobeNewsWire

More News